117 related articles for article (PubMed ID: 7688321)
1. Cyclic disulfide model of the major antigenic site of serotype-C foot-and-mouth disease virus. Synthetic, conformational and immunochemical studies.
Camarero JA; Andreu D; Cairó JJ; Mateu MG; Domingo E; Giralt E
FEBS Lett; 1993 Aug; 328(1-2):159-64. PubMed ID: 7688321
[TBL] [Abstract][Full Text] [Related]
2. Native-like cyclic peptide models of a viral antigenic site: finding a balance between rigidity and flexibility.
Valero ML; Camarero JA; Haack T; Mateu MG; Domingo E; Giralt E; Andreu D
J Mol Recognit; 2000; 13(1):5-13. PubMed ID: 10679891
[TBL] [Abstract][Full Text] [Related]
3. Cyclic peptides as conformationally restricted models of viral antigens: application to foot-and-mouth disease virus.
Valero ML; Camarero JA; Adeva A; Verdaguer N; Fita I; Mateu MG; Domingo E; Giralt E; Andreu D
Biomed Pept Proteins Nucleic Acids; 1995; 1(3):133-40. PubMed ID: 9346844
[TBL] [Abstract][Full Text] [Related]
4. Antigenicity modulation upon peptide cyclization: application to the GH loop of foot-and-mouth disease virus strain C1-Barcelona.
Gomes P; Giralt E; Andreu D
Vaccine; 2001 May; 19(25-26):3459-66. PubMed ID: 11348711
[TBL] [Abstract][Full Text] [Related]
5. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C.
Mateu MG; Martínez MA; Capucci L; Andreu D; Giralt E; Sobrino F; Brocchi E; Domingo E
J Gen Virol; 1990 Mar; 71 ( Pt 3)():629-37. PubMed ID: 1690261
[TBL] [Abstract][Full Text] [Related]
6. A cyclic disulfide peptide reproduces in solution the main structural features of a native antigenic site of foot-and-mouth disease virus.
Haack T; Camarero JA; Roig X; Mateu MG; Domingo E; Andreu D; Giralt E
Int J Biol Macromol; 1997 Jun; 20(3):209-19. PubMed ID: 9218170
[TBL] [Abstract][Full Text] [Related]
7. Conformational preferences of a peptide corresponding to the major antigenic determinant of foot-and-mouth disease virus: implications for peptide-vaccine approaches.
de Prat-Gay G
Arch Biochem Biophys; 1997 May; 341(2):360-9. PubMed ID: 9169027
[TBL] [Abstract][Full Text] [Related]
8. Correlations between the conformations elucidated by CD spectroscopy and the antigenic properties of four peptides of the foot-and-mouth disease virus.
Siligardi G; Drake AF; Mascagni P; Rowlands D; Brown F; Gibbons WA
Eur J Biochem; 1991 Aug; 199(3):545-51. PubMed ID: 1651235
[TBL] [Abstract][Full Text] [Related]
9. A multiply substituted G-H loop from foot-and-mouth disease virus in complex with a neutralizing antibody: a role for water molecules.
Ochoa WF; Kalko SG; Mateu MG; Gomes P; Andreu D; Domingo E; Fita I; Verdaguer N
J Gen Virol; 2000 Jun; 81(Pt 6):1495-505. PubMed ID: 10811933
[TBL] [Abstract][Full Text] [Related]
10. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents.
Parry NR; Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1493-503. PubMed ID: 2471812
[TBL] [Abstract][Full Text] [Related]
11. Studies on antigenic variability of C strains of foot-and-mouth disease virus by means of synthetic peptides and monoclonal antibodies.
Carreño C; Roig X; Cairo J; Camarero J; Mateu MG; Domingo E; Giralt E; Andreu D
Int J Pept Protein Res; 1992 Jan; 39(1):41-7. PubMed ID: 1378821
[TBL] [Abstract][Full Text] [Related]
12. The structure and antigenicity of a type C foot-and-mouth disease virus.
Lea S; Hernández J; Blakemore W; Brocchi E; Curry S; Domingo E; Fry E; Abu-Ghazaleh R; King A; Newman J
Structure; 1994 Feb; 2(2):123-39. PubMed ID: 8081743
[TBL] [Abstract][Full Text] [Related]
13. Antibodies raised in a natural host and monoclonal antibodies recognize similar antigenic features of foot-and-mouth disease virus.
Mateu MG; Andreu D; Domingo E
Virology; 1995 Jun; 210(1):120-7. PubMed ID: 7793064
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.
Barnett PV; Samuel AR; Pullen L; Ansell D; Butcher RN; Parkhouse RM
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132
[TBL] [Abstract][Full Text] [Related]
15. Antibody and host cell recognition of foot-and-mouth disease virus (serotype C) cleaved at the Arg-Gly-Asp (RGD) motif: a structural interpretation.
Hernández J; Valero ML; Andreu D; Domingo E; Mateu MG
J Gen Virol; 1996 Feb; 77 ( Pt 2 )():257-64. PubMed ID: 8627229
[TBL] [Abstract][Full Text] [Related]
16. Use of substituted and tandem-repeated peptides to probe the relevance of the highly conserved RGD tripeptide in the immune response against foot-and-mouth disease virus.
Novella IS; Borrego B; Mateu MG; Domingo E; Giralt E; Andreu D
FEBS Lett; 1993 Sep; 330(3):253-9. PubMed ID: 7690714
[TBL] [Abstract][Full Text] [Related]
17. Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies.
Bolwell C; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
J Gen Virol; 1989 Jan; 70 ( Pt 1)():59-68. PubMed ID: 2471783
[TBL] [Abstract][Full Text] [Related]
18. A CD strategy for the study of polypeptide folding/unfolding. A synthetic foot-and-mouth disease virus immunogenic peptide.
Siligardi G; Drake AF; Mascagni P; Rowlands DJ; Brown F; Gibbons WA
Int J Pept Protein Res; 1991 Dec; 38(6):519-27. PubMed ID: 1726426
[TBL] [Abstract][Full Text] [Related]
19. A high proportion of anti-peptide antibodies recognize foot-and-mouth disease virus particles.
Parry NR; Syred A; Rowlands DJ; Brown F
Immunology; 1988 Aug; 64(4):567-72. PubMed ID: 2844657
[TBL] [Abstract][Full Text] [Related]
20. Functional mimicry of a discontinuous antigenic site by a designed synthetic peptide.
Villén J; Borràs E; Schaaper WM; Meloen RH; Dávila M; Domingo E; Giralt E; Andreu D
Chembiochem; 2002 Mar; 3(2-3):175-82. PubMed ID: 11921395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
